By C. Khor
A state‑linked healthcare corporation’s expansion of private hospitals has sparked unease among those who believe public money should first and foremost strengthen the public healthcare system.
The concern is not about the existence of private healthcare. Few would deny its role in offering choice, convenience and specialised services.
The real issue is whether scarce state resources should be channelled into expanding private hospital networks when government‑run hospitals are already straining under shortages of staff, facilities and funding.
The matter was recently raised by Parti Sosialis Malaysia deputy secretary-general, Gandipan Nantha Gopalan, who highlighted that Malaysia’s public healthcare system already faces chronic challenges. They include specialist doctors leaving for better pay, nurses stretched thin, and facilities struggling to keep pace with demand.
In such a climate, building new private hospitals does not necessarily increase overall capacity. It risks drawing from the same limited pool of healthcare workers, intensifying competition and leaving public hospitals even more depleted.
Proponents of state‑backed private hospitals often point to corporate social responsibility programmes — free screenings, discounted treatments, or community outreach — as evidence of public benefit.
But these gestures do not change the fundamental reality: a private hospital, even if state‑owned, operates on commercial logic. Its survival depends on paying patients, not on universal access.
The larger question is one of priorities. Should state capital and landbanks be leveraged to grow private healthcare businesses, or should they be directed toward easing bottlenecks in government hospitals where the majority of Malaysians seek care? Transparency is key. Citizens deserve to know how much public investment is being channelled into private ventures, and why such investments are deemed more urgent than bolstering public facilities.
This debate is not about ideology but about equity. Expanding private hospitals may look like progress, but if it comes at the expense of public healthcare, it risks widening the gap between those who can afford treatment and those who cannot.
Healthcare is not just another sector for investment returns. It is a lifeline.
When state resources are deployed, they should serve the broadest public interest — ensuring that access, affordability and quality are strengthened where they are needed most. Anything less is a misalignment of priorities.
WE